WO2002087517A2 - Verwendung von isoflavonoiden in kosmetischen oder dermatologischen zubereitungen zur prophylaxe vor und behandlung von sensibler haut - Google Patents
Verwendung von isoflavonoiden in kosmetischen oder dermatologischen zubereitungen zur prophylaxe vor und behandlung von sensibler haut Download PDFInfo
- Publication number
- WO2002087517A2 WO2002087517A2 PCT/EP2002/004625 EP0204625W WO02087517A2 WO 2002087517 A2 WO2002087517 A2 WO 2002087517A2 EP 0204625 W EP0204625 W EP 0204625W WO 02087517 A2 WO02087517 A2 WO 02087517A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- skin
- isoflavone
- cosmetic
- dihydroxy
- methoxy
- Prior art date
Links
- 0 *CCN1C(c(c(O)c2)ccc2O*)NC(*)NC1c(ccc(O*)c1)c1O Chemical compound *CCN1C(c(c(O)c2)ccc2O*)NC(*)NC1c(ccc(O*)c1)c1O 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/066—Multiple emulsions, e.g. water-in-oil-in-water
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02766639A EP1392239A2 (de) | 2001-05-02 | 2002-04-26 | Verwendung von isoflavonoiden in kosmetischen oder dermatologischen zubereitungen zur prophylaxe vor und behandlung von sensibler haut |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2001121375 DE10121375B4 (de) | 2001-05-02 | 2001-05-02 | Verwendung von Isoflavonoiden in kosmetischen oder dermatologischen Zubereitungen zur Prophylaxe vor und Behandlung von sensibler Haut |
DE10121375.1 | 2001-05-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002087517A2 true WO2002087517A2 (de) | 2002-11-07 |
WO2002087517A3 WO2002087517A3 (de) | 2003-02-27 |
Family
ID=7683395
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2002/004625 WO2002087517A2 (de) | 2001-05-02 | 2002-04-26 | Verwendung von isoflavonoiden in kosmetischen oder dermatologischen zubereitungen zur prophylaxe vor und behandlung von sensibler haut |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1392239A2 (de) |
DE (1) | DE10121375B4 (de) |
WO (1) | WO2002087517A2 (de) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004082697A1 (en) * | 2003-03-21 | 2004-09-30 | Unilever Plc | Compositions of natural products and use thereof |
EP1534232A1 (de) * | 2002-09-06 | 2005-06-01 | Novogen Research Pty. Ltd. | REPARATUR VON MUTAGENEN DNA-SCHûDEN |
EP1542654A1 (de) * | 2002-09-23 | 2005-06-22 | Novogen Research Pty. Ltd. | Hautbehandlung bei lichtalterung und aktinischen schäden |
EP1740191A1 (de) * | 2004-04-28 | 2007-01-10 | Brigham Young University | Verwendung von equol zur behandlung von hauterkrankungen |
WO2007029198A2 (en) * | 2005-09-09 | 2007-03-15 | The Procter & Gamble Company | Sanitary napkins with hydrophobic lotions |
US7396855B2 (en) | 2002-07-24 | 2008-07-08 | Children's Hospital Medical Center | Compositions and products containing S-equol, and methods for their making |
US8153684B2 (en) | 2002-10-29 | 2012-04-10 | Colorado State University Research Foundation | Use of equol for treating androgen mediated diseases |
US8580846B2 (en) | 2002-10-29 | 2013-11-12 | Brigham Young University | Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders |
US8668914B2 (en) | 2002-07-24 | 2014-03-11 | Brigham Young University | Use of equol for treating skin diseases |
US8795716B2 (en) | 2001-10-01 | 2014-08-05 | The Procter & Gamble Company | Skin care compositions on a thin sanitary napkin |
US8907154B2 (en) | 2001-10-01 | 2014-12-09 | The Procter & Gamble Company | Sanitary napkins with hydrophobic lotions |
US9035123B2 (en) | 2002-10-01 | 2015-05-19 | The Procter & Gamble Company | Absorbent article having a lotioned topsheet |
KR20200092748A (ko) * | 2019-01-25 | 2020-08-04 | 서울대학교산학협력단 | 오로볼을 유효성분으로 포함하는 아토피 피부염의 개선 또는 치료용 조성물 |
CN115634225A (zh) * | 2022-10-19 | 2023-01-24 | 中南大学湘雅医院 | 肌肽作为活性成分在制备银屑病治疗药物中的应用 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10301632A1 (de) * | 2003-01-17 | 2004-07-29 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Kreatin, Kreatinin und/oder seinen Derivaten in Kombination mit Sojabohnenkeimextrakten |
DE10301631A1 (de) * | 2003-01-17 | 2004-07-29 | Beiersdorf Ag | Kosmetische und dermatologische Zubereitungen mit einem Gehalt an Sojabohnenkeimextrakten in Kombination mit Vitamin C und/oder E sowie alpha-Glycosylrutin |
DE10316666B4 (de) * | 2003-04-10 | 2015-04-09 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitungen mit einer Kombination von Kreatinin mit Kreatin und Coenzym Q10 |
DE102004032837A1 (de) * | 2004-07-02 | 2006-02-09 | Beiersdorf Ag | Verwendung von Wirkstoffkombinationen aus einem oder mehreren Biochinonen und einem oder mehreren Isoflavonen zur Verbesserung der Hautkonturen |
KR101782966B1 (ko) * | 2017-03-14 | 2017-09-28 | 전북대학교산학협력단 | 가려움증의 예방 또는 치료용 조성물 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4432947A1 (de) * | 1994-09-16 | 1996-03-21 | New Standard Gmbh | Mittel zur Behandlung der Haut |
WO1998056373A1 (en) * | 1997-06-11 | 1998-12-17 | Gorbach Sherwood L | Isoflavonoids for treatment and prevention of aging skin and wrinkles |
WO1999047118A1 (en) * | 1998-03-16 | 1999-09-23 | The Procter & Gamble Company | Compositions for regulating skin appearance |
WO2001008652A1 (en) * | 1999-07-30 | 2001-02-08 | Unilever Plc | Skin care composition |
WO2001008651A1 (en) * | 1999-07-30 | 2001-02-08 | Unilever Plc | Skin care composition |
EP1104672A1 (de) * | 1999-12-02 | 2001-06-06 | Laboratoires Serobiologiques(Societe Anonyme) | Kosmetische und/oder pharmazeutische Zubereitungen |
EP1180331A1 (de) * | 2000-08-16 | 2002-02-20 | Unilever N.V. | Mischungen von Isoflavonen und Flavonen |
WO2002066001A1 (fr) * | 2001-02-21 | 2002-08-29 | Laboratoires Expanscience | Solution topique contenant un derive de chromane ou de chromene |
WO2002076409A2 (de) * | 2001-03-23 | 2002-10-03 | Beiersdorf Ag | Kosmetische und dermatologische zubereitungen mit einem gehalt an isoflavonen |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1059956A (ja) * | 1996-08-22 | 1998-03-03 | Kikkoman Corp | 新規イソフラボン誘導体及びその製造法 |
US6224872B1 (en) * | 1997-07-31 | 2001-05-01 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Composition |
AUPP112497A0 (en) * | 1997-12-24 | 1998-01-22 | Novogen Research Pty Ltd | Compositions and method for protecting skin from UV induced immunosupression and skin damage |
-
2001
- 2001-05-02 DE DE2001121375 patent/DE10121375B4/de not_active Expired - Fee Related
-
2002
- 2002-04-26 EP EP02766639A patent/EP1392239A2/de not_active Withdrawn
- 2002-04-26 WO PCT/EP2002/004625 patent/WO2002087517A2/de not_active Application Discontinuation
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4432947A1 (de) * | 1994-09-16 | 1996-03-21 | New Standard Gmbh | Mittel zur Behandlung der Haut |
WO1998056373A1 (en) * | 1997-06-11 | 1998-12-17 | Gorbach Sherwood L | Isoflavonoids for treatment and prevention of aging skin and wrinkles |
WO1999047118A1 (en) * | 1998-03-16 | 1999-09-23 | The Procter & Gamble Company | Compositions for regulating skin appearance |
WO2001008652A1 (en) * | 1999-07-30 | 2001-02-08 | Unilever Plc | Skin care composition |
WO2001008651A1 (en) * | 1999-07-30 | 2001-02-08 | Unilever Plc | Skin care composition |
EP1104672A1 (de) * | 1999-12-02 | 2001-06-06 | Laboratoires Serobiologiques(Societe Anonyme) | Kosmetische und/oder pharmazeutische Zubereitungen |
EP1180331A1 (de) * | 2000-08-16 | 2002-02-20 | Unilever N.V. | Mischungen von Isoflavonen und Flavonen |
WO2002066001A1 (fr) * | 2001-02-21 | 2002-08-29 | Laboratoires Expanscience | Solution topique contenant un derive de chromane ou de chromene |
WO2002076409A2 (de) * | 2001-03-23 | 2002-10-03 | Beiersdorf Ag | Kosmetische und dermatologische zubereitungen mit einem gehalt an isoflavonen |
Non-Patent Citations (2)
Title |
---|
MIYAZAKI KOUJI ET AL: "Dermatological researches of isoflavone and Bifidobacterium-fermented soy milk extract" CAPLUS, XP002183472 * |
POLA CHEMICAL INDUSTRIES: "Skin stress-decreasing compositions containing isoflavone or flavone derivatives" CAPLUS, XP002212265 * |
Cited By (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8907154B2 (en) | 2001-10-01 | 2014-12-09 | The Procter & Gamble Company | Sanitary napkins with hydrophobic lotions |
US8795716B2 (en) | 2001-10-01 | 2014-08-05 | The Procter & Gamble Company | Skin care compositions on a thin sanitary napkin |
US7960432B2 (en) | 2002-07-24 | 2011-06-14 | Children's Hospital Medical Center | Compositions and products containing S-equol, and methods for their making |
US9408824B2 (en) | 2002-07-24 | 2016-08-09 | Children's Hospital Medical Center | Compositions and products containing S-equol, and methods for their making |
US9173866B2 (en) | 2002-07-24 | 2015-11-03 | Children's Hospital Medical Center | Compositions and products containing R-equol, and methods for their making |
US9018247B2 (en) | 2002-07-24 | 2015-04-28 | Children's Hospital Medical Center | Compositions and products containing S-equol, and methods for their making |
US7396855B2 (en) | 2002-07-24 | 2008-07-08 | Children's Hospital Medical Center | Compositions and products containing S-equol, and methods for their making |
US8668914B2 (en) | 2002-07-24 | 2014-03-11 | Brigham Young University | Use of equol for treating skin diseases |
US8048913B2 (en) | 2002-07-24 | 2011-11-01 | Australian Health & Nutrition Assoc. Ltd. | Compositions and products containing S-equol, and methods for their making |
EP1534232A1 (de) * | 2002-09-06 | 2005-06-01 | Novogen Research Pty. Ltd. | REPARATUR VON MUTAGENEN DNA-SCHûDEN |
EP1534232A4 (de) * | 2002-09-06 | 2008-12-24 | Novogen Res Pty Ltd | REPARATUR VON MUTAGENEN DNA-SCHûDEN |
EP1542654A4 (de) * | 2002-09-23 | 2008-12-17 | Novogen Res Pty Ltd | Hautbehandlung bei lichtalterung und aktinischen schäden |
EP1542654A1 (de) * | 2002-09-23 | 2005-06-22 | Novogen Research Pty. Ltd. | Hautbehandlung bei lichtalterung und aktinischen schäden |
US9035123B2 (en) | 2002-10-01 | 2015-05-19 | The Procter & Gamble Company | Absorbent article having a lotioned topsheet |
US10687991B2 (en) | 2002-10-01 | 2020-06-23 | The Procter & Gamble Company | Absorbent article having a lotioned topsheet |
US9737446B2 (en) | 2002-10-01 | 2017-08-22 | The Procter & Gamble Company | Absorbent article having a lotioned topsheet |
US9889116B2 (en) | 2002-10-29 | 2018-02-13 | Bringham Young University | Use of equol for treating androgen mediated diseases |
US9408825B2 (en) | 2002-10-29 | 2016-08-09 | Brigham Young University | Use of equol for treating androgen mediated diseases |
US10111855B2 (en) | 2002-10-29 | 2018-10-30 | Brigham Young University | Use of equol for treating androgen mediated diseases |
US8153684B2 (en) | 2002-10-29 | 2012-04-10 | Colorado State University Research Foundation | Use of equol for treating androgen mediated diseases |
US9089547B2 (en) | 2002-10-29 | 2015-07-28 | Brigham Young University | Use of equol for treating androgen mediated diseases |
US8580846B2 (en) | 2002-10-29 | 2013-11-12 | Brigham Young University | Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders |
WO2004082697A1 (en) * | 2003-03-21 | 2004-09-30 | Unilever Plc | Compositions of natural products and use thereof |
EP1740191A1 (de) * | 2004-04-28 | 2007-01-10 | Brigham Young University | Verwendung von equol zur behandlung von hauterkrankungen |
JP2007534751A (ja) * | 2004-04-28 | 2007-11-29 | ブリガム・ヤング・ユニバーシティ | 皮膚疾患を処置するためのイコールの使用 |
EP2305272A1 (de) * | 2004-04-28 | 2011-04-06 | Brigham Young University | Verwendung von Equol zur Behandlung von Hauterkrankungen |
EP1740191A4 (de) * | 2004-04-28 | 2008-07-30 | Univ Brigham Young | Verwendung von equol zur behandlung von hauterkrankungen |
WO2007029198A2 (en) * | 2005-09-09 | 2007-03-15 | The Procter & Gamble Company | Sanitary napkins with hydrophobic lotions |
WO2007029198A3 (en) * | 2005-09-09 | 2009-01-08 | Procter & Gamble | Sanitary napkins with hydrophobic lotions |
KR101006258B1 (ko) * | 2005-09-09 | 2011-01-06 | 더 프록터 앤드 갬블 캄파니 | 소수성 로션을 포함하는 생리대 |
KR20200092748A (ko) * | 2019-01-25 | 2020-08-04 | 서울대학교산학협력단 | 오로볼을 유효성분으로 포함하는 아토피 피부염의 개선 또는 치료용 조성물 |
KR102143159B1 (ko) | 2019-01-25 | 2020-08-10 | 서울대학교산학협력단 | 오로볼을 유효성분으로 포함하는 아토피 피부염의 개선 또는 치료용 조성물 |
CN115634225A (zh) * | 2022-10-19 | 2023-01-24 | 中南大学湘雅医院 | 肌肽作为活性成分在制备银屑病治疗药物中的应用 |
Also Published As
Publication number | Publication date |
---|---|
EP1392239A2 (de) | 2004-03-03 |
WO2002087517A3 (de) | 2003-02-27 |
DE10121375A1 (de) | 2002-11-07 |
DE10121375B4 (de) | 2014-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE10032964B4 (de) | Verwendung von Kreatin in kosmetischen oder dermatologischen Zubereitungen | |
DE10121375B4 (de) | Verwendung von Isoflavonoiden in kosmetischen oder dermatologischen Zubereitungen zur Prophylaxe vor und Behandlung von sensibler Haut | |
DE19933461A1 (de) | Verwendung von Ectoinen und UV-Filtern | |
EP1127568A2 (de) | Kosmetische und dermatologische Lichtshutzformulierungen mit einem Gehalt an Benzotriazolderivaten und Alkylnapthalaten | |
EP1406585A2 (de) | Verwendung von hopfen- bzw. hopfen-malz-extrakten in kosmetischen oder dermatologischen zubereitungen | |
EP0945126A2 (de) | Kosmetische oder dermatologische Zusammnestzung bestehend aus Carnitin und/oder einen Acylcarnitin, und mindestens einem Antioxidans | |
DE10048260A1 (de) | Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Aminoguanidin und/oder dessen Derivaten und Strukturanaloga zur Hautaufhellung von Altersflecken und/oder zur Verhinderung der Hautbräunung, insbesondere der durch UV-Strahlung hervorgerufenen Hautbräunung | |
WO2002089757A2 (de) | Verwendung von isoflavonen in kosmetischen oder dermatologischen zubereitungen | |
EP1311234A2 (de) | Substanzen zur induktion und intensivierung der bräunungsmechanismen der haut | |
EP1414401A1 (de) | Verwendung von kreatinin und/oder kreatininderivaten in kosmetischen oder dermatologischen zubereitungen | |
WO2002087533A1 (de) | Verwendung von klee-extrakt zur prophylaxe gegen und behandlung von degenerativen hauterscheinungen | |
EP0935959B1 (de) | Verwendung von Bienenwachs zur Verstärkung der UV-A-Schutzleistung kosmetischer oder dermatologischer Formulierungen | |
EP1000603B1 (de) | Verwendung von oberflächenaktiven Citronensäureestern zur Stabilisierung von Flavonen, Flavanonen bzw. Flavonoiden, synergistische Gemische aus Flavonen, Flavanonen bzw. Flavonoiden und oberflächenaktiven Substanzen sowie kosmetische und dermatologische Zubereitungen mit einem Gehalt an solchen Gemischen | |
EP1539206A1 (de) | Kosmetische oder dermatologische zubereitungen mit einem gehalt an anti-freezing proteinen und/oder anti-freezing glycoproteinen | |
DE10212865B4 (de) | Verwendung von 9-Retinal-alkanolamin Schiffsche Base in kosmetischen der dermatologischen Formulierungen | |
EP1311233B1 (de) | Substanzen zur induktion und intensivierung der bräunungsmechanismen der haut und kosmetische oder dermatologische formulierungen dieselben enthaltend | |
DE19845324A1 (de) | Verwendung von Nitrilotriessigsäure zur Stabilisierung von Flavonen, Flavanonen bzw. Flavonoiden, synergistische Gemische aus Flavonen, Flavanonen bzw. Flavonoiden und Nitrilessigsäure sowie kosmetische und dermatologische Zubereitungen mit einem Gehalt an solchen Gemischen | |
DE10131796A1 (de) | Verwendung von Cardiolipin in kosmetischen oder dermatologischen Zubereitungen | |
DE19845319A1 (de) | Verwendung von oberflächenaktiven Substanzen zur Stabilisierung von Flavonen, Flavanonen bzw. Flavonoiden, synergistische Gemische aus Flavonen, Flavanonen bzw. Flavonoiden und oberflächenaktiven Substanzen sowie kosmetische und dermatologische Zubereitungen mit einem Gehalt an solchen Gemischen | |
DE10141681A1 (de) | Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Anti-Freezing Proteinen und/oder Anti-freezing Glycoproteinen | |
DE19845266A1 (de) | Verwendung von Butylhydroxytoluol zur Stabilisierung von Flavonen, Flavanonen bzw. Flavonoiden, synergistische Gemische aus Flavonen, Flavanonen bzw. Flavonoiden und Butylhydroxytoluol sowie kosmetische und dermatologische Zubereitungen mit einem Gehalt an solchen Gemischen | |
DE10048261A1 (de) | Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Pyridoxamin zur Hautaufhellung von Altersflecken und/oder zur Verhinderung der Hautbräunung, insbesondere der durch UV-Strahlung hervorgerufenen Hautbräunung | |
DE10140537A1 (de) | Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Triazinen und/oder Triazinderivaten und Iminodibernsteinsäure und/oder ihren Salzen | |
DE10140536A1 (de) | Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Benzotriazolen und Iminodibernsteinsäure und/oder ihren Salzen | |
EP0864313A2 (de) | Verwendung von Benzophenonen und deren Derivaten gegen die UV-induzierte Zersetzung von Dibenzoylmethan und dessen Derivaten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002766639 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002766639 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002766639 Country of ref document: EP |